Recent studies have shown that PPIL2 affects the epithelial–mesenchymal transition (EMT) process through SNAl1 ubiquitination and degradation, which inhibits migration and invasion of breast cancer cells (Jia et al., 2017). The gene discussed is PPIL2; the disease is breast carcinoma.